ONCOLYTIC VIROTHERAPY WITH INDUCED ANTI-TUMOR IMMUNITY

摘要

Provided are improved oncolytic viruses with increased bystander cell killing and induced anti-tumor immunity. The oncolytic viruses include an oncolytic herpes virus backbone genetically modified to encode a tumor cell binding component and an immunoglobulin (Ig) binding component.